Market Research Logo

Global Botulinum Toxin Market: Size, Trends and Forecasts (2016-2020)

Global Botulinum Toxin Market: Size, Trends and Forecasts (2016-2020)

Scope of the Report

The report titled “Global Botulinum Toxin Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global botulinum toxin market with detailed analysis of the actual and the expected market size along with the market size of each market segment on the basis of indication as well as products.

The report provides detailed regional analysis of the U.S., European Union, Japan and Korea for the botulinum toxin market. Regional analysis includes market share of each region or country and the actual and forecasted market size of the botulinum toxin market along with the market segments of the aforementioned regions.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global botulinum toxin market has also been forecasted for the period 2016-2020, taking into consideration the previous growth patterns, the growth drivers and the current and future trends. The competition in the global botulinum toxin market is stiff and dominated by the big players like Allergan. Further, key players of the botulinum toxin market Ipsen and Revance are also profiled with their financial information and respective business strategies.

Regional Coverage

The U.S.
European Union
Japan
Korea

Company Coverage

Allergan PLC.
Ipsen
Revance Therapeutics, Inc.

Executive Summary

Botulinum toxin is produced by clostridium botulinum, a gram-positive anaerobic bacterium. It is broken into seven neurotoxins. Currently, it is used in almost every sub-specialty of medicine and for cosmetic purpose for temporarily reducing glabeller forehead frown lines. The various botulinum toxins possess individual potencies, and care is required to assure proper use and avoid medication errors.

The global botulinum toxin market has increased at a significant annual growth rate in 2015 as compared to the preceding year 2014 and projections are made that the market would rise in the next five years i.e. 2016-2020 tremendously. The upsurge in the market was due to various factors such as increased patient comfort, shorter procedure times and immediate results. The market can be segmented on the basis of indications as therapeutics and aesthetics, of which therapeutics govern the market.

The major growth drivers for the botulinum toxin market are: upsurge in the facial aesthetics market, reduction in prices of botulinum toxin treatment and social awareness among people. Despite the market is governed by various growth drivers, there are certain challenges faced by the market such as side-effects of consuming botulinum toxin and bioterrorism.


1. Executive Summary
2. Introduction
2.1 Sub-Types of Botulinum Toxin
2.2 Indications for Botulinum Toxin
Table A: Applicable Indications of Botulinum Toxin
2.3 Botulinum Toxin Products
Table 1: Botulinum Toxin Products
Botox
Dysport
Myobloc
Xeomin
3. Global Botulinum Toxin Market: An Analysis
3.1 Global Botulinum Toxin Market by Value: Actual and Forecast
Table 2: Global Botulinum Toxin Market by Value; 2013-2015 (US$ Billion)
Table 3: Global Botulinum Toxin Market by Value; 2016E-2020E (US$ Billion)
3.2 Global Botulinum Toxin Market by Indication Segments
Table 4: Global Botulinum Toxin Market by Indication Segments; 2015 (%)
3.2.1 Global Therapeutic Botulinum Toxin Market by Value: Actual and Forecast
Table 5: Global Therapeutic Botulinum Toxin Market by Value; 2013-2020E (US$ Billion)
3.2.2 Global Therapeutic Botulinum Toxin Market by Indications
Table 6: Global Therapeutic Botulinum Toxin Market by Indication; 2015 (%)
3.2.3 Global Aesthic Botulinum Toxin Market by Value: Actual and Forecast
Table 7: Global Aesthetic Botulinum Toxin Market by Value; 2013-2020E (US$ Billion)
3.2.4 Global Aesthetic Botulinum Toxin Market by Number of Cases
Table 8: Global Aesthetic Botulinum Toxin Market by Number of Cases; 2010-2014 (Million)
3.3 Global Botulinum Toxin Market by Product Segments
Table 9: Global Botulinum Toxin Market by Product Segments; 2015 (%)
3.3.1 Global Botox Market by Value: Actual and Forecast
Table 10: Global Botox Market by Value; 2013-2020E (US$ Billion)
3.3.2 Global Dysport Market by Value: Actual and Forecast
Table 11: Global Dysport Market by Value; 2013-2020E (US$ Million)
3.3.3 Global Xeomin Market by Value: Actual and Forecast
Table 12: Global Xeomin Market by Value; 2013-2020E (US$ Million)
3.3.4 Global Myobloc Market by Value: Actual and Forecast
Table 13: Global Myobloc Market by Value; 2013-2020E (US$ Million)
3.4 Global Botulinum Toxin Market by Regions
Table 14: Global Botulinum Toxin Market by Regions; 2015 (%)
4. Regional Botulinum Toxin Market: An Analysis
4.1 The U.S. Botulinum Toxin Market: Sizing and Growth
4.1.1 The U.S. Botulinum Toxin Market by Value: Actual and Forecast
Table 15: The U.S. Botulinum Toxin Market by Value; 2013-2015 (US$ Billion)
Table 16: The U.S. Botulinum Toxin Market by Value; 2016E-2020E (US$ Billion)
4.1.2 The U.S. Botulinum Toxin Market by Indication Segments: Actual and Forecast
Table 17: The U.S. Botulinum Toxin Market by Indication Segments; 2013-2020E (US$ Billion)
4.1.3 The U.S. Aesthetic Botulinum Toxin Market by Number of Cases
Table 18: The U.S. Aesthetic Botulinum Toxin Market by Number of Cases; 2010-2014 (Million)
4.2 European Union Botulinum Toxin Market: Sizing and Growth
4.2.1 European Union Botulinum Toxin Market by Value: Actual and Forecast
Table 19: European Union Botulinum Toxin Market by Value; 2013-2015 (US$ Billion)
Table 20: European Union Botulinum Toxin Market by Value; 2016E-2020E (US$ Billion)
4.2.2 European Union Botulinum Toxin Market by Indication Segments: Actual and Forecast
Table 21: European Union Botulinum Toxin Market by Indication Segments; 2013-2020E (US$ Million)
4.3 Japan Botulinum Toxin Market: Sizing and Growth
4.3.1 Japan Botulinum Toxin Market by Value: Actual and Forecast
Table 22: Japan Botulinum Toxin Market by Value; 2013-2015 (US$ Million)
Table 23: Japan Botulinum Toxin Market by Value; 2016E-2020E (US$ Million)
4.3.2 Japan Botulinum Toxin Market by Indication Segments: Actual and Forecast
Table 24: Japan Botulinum Toxin Market by Indication Segments; 2013-2020E (US$ Million)
4.3.3 Japan Aesthetic Botulinum Toxin Market by Number of Cases
Table 25: Japan Aesthetic Botulinum Toxin Market by Number of Cases; 2010-2014 (Thousand)
4.4 Korea Botulinum Toxin Market: Sizing and Growth
4.4.1 Korea Botulinum Toxin Market by Value: Actual and Forecast
Table 26: Korea Botulinum Toxin Market by Value; 2013-2015 (US$ Million)
Table 27: Korea Botulinum Toxin Market by Value; 2016E-2020E (U$ Million)
4.4.2 South Korea Aesthetic Botulinum Toxin Market by Number of Cases
Table 28: South Korea Aesthetic Botulinum Toxin Market by Number of Cases; 2010-2014 (Thousand)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Facial Aesthetic Market
Table 29: Global Botulinum Toxin Market for Facial Aesthetic Treatment; 2011-2016E (US$ Billion)
5.1.2 Reducing Price Trend
Table 30: The U.S. Average Medical Expenditure for Aesthetic Botulinum Toxin Procedures; 2010-2014 (US$)
5.1.3 Social Awareness
5.2 Challenges
5.2.1 Side-Effects of Botulinum Toxin for Consumers
5.2.2 Bioterrorism
5.3 Market Trends
5.3.1 RT001 and RT002
Table 31: Global RT001/RT002 Market; 2019E-2025E (US$ Million)
6. Competitive Landscape
6.1 Global Botulinum Toxin Companies Product Comparison
Table 32: Global Botulinum Toxin Market by Players; 2015 (%)
Table B: Staus of Global Botulinum Toxin Companies
6.2 Korea Botulinum Toxin Companies Product Comparison
Table C: Status of Korean Botulinum Toxin Companies
7. Company Profile
7.1 Allergan PLC.
7.1.1 Business Overview
7.1.2 Financial Overview
Table 33: Allergan PLC. Total Revenues; 2011-2015 (US$ Billion)
Table 34: Allergan PLC. Revenues by Segments; 2015 (%)
Table 35: Allergan PLC. Revenues by Products
7.1.3 Business Strategy
Mergers and Acquisitions
Introduction of New Products
Table D: Allergan PLC. Products yet to be Launched
7.2 Ipsen
7.2.1 Business Overview
7.2.2 Financial Overview
Table 36: Ipsen Total Revenues; 2011-2015 (US$ Billion)
Table 37: Ipsen Revenues by Segments; 2015 (%)
Table 38: Ipsen Sales by Regions; 2015 (%)
7.2.3 Business Strategy
Partnerships and Collaborations
Licensing Agreements
7.3 Revance Therapeutics, Inc.
7.3.1 Business Overview
RT001
RT002
7.3.2 Financial Overview
Table 39: Revance Therapeutics, Inc. Total Revenues; 2011-2015 (US$ Thousand)
7.3.3 Business Strategy
Research and Development
Table 40: Revance Therapeutics Inc., Research and Development Expenditure; 2011-2015 (US$ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report